PubMed Health⌕ Search

PubMed · 12152184

The Millennium Cohort Study.

Abstract

The Millennium Cohort Study is the latest in the line of British birth cohort studies. MCS resembles its predecessors which follow people born in 1946, 1958 and 1970 in the intention to become multi-purpose longitudinal data resource charting many aspects of individual's lives over time. The families of a sample of around 20,000 babies are being interviewed during 2001-02, when eligible babies reach 9 months, to establish the conditions from which they set out in life. The survey contrasts with the previous cohort studies in various ways. Instead of taking all births in one week, the sample of births is spread over a year; the births are from a selection of electoral wards, thereby enabling eventual analysis by neighbourhood characteristics; it also over samples children living in deprived areas, wards with high ethnic minority populations and samples have been boosted in Scotland, Wales and Northern Ireland. The latter UK country has not been covered by the other studies. It interviews fathers as well as mothers, and given that its initial funding comes via the ESRC, puts a greater emphasis on socio-economic data than in early parts of the other studies. MCS has been enhanced by additional Government funding. The research team, based at the Institute of Education, aims to deposit a multi-purpose dataset for public use at the ESRC data Archive in the Spring of 2003.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kate Smith, Heather Joshi. 2002. The Millennium Cohort Study.. https://pubmed.ncbi.nlm.nih.gov/12152184/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry.

This is the second report on the continuing efforts of LAGID to increase the recognition and registration of patients with primary immunodeficiency diseases in 12 Latin American countries: Argentina, Brazil, Chile, Colombia, Costa Rica, Honduras, Mexico, Panama, Paraguay, Peru, Uruguay, and Venezuela. This report reveals that from a total of 3321 patients registered, the most common form of primary immunodeficiency disease was predominantly antibody deficiency (53.2%) with IgA deficiency reported as the most frequent phenotype. This category was followed by 22.6% other well-defined ID syndromes, 9.5% combined T- and B-cell inmunodeficiency, 8.6% phagocytic disorders, 3.3% diseases of immune dysregulation, and 2.8% complement deficiencies. All countries that participated in the first publication in 1998 reported an increase in registered primary immunodeficiency cases, ranging between 10 and 80%. A comparison of the estimated minimal incidence of X-linked agammaglobulinemia, chronic granulomatous disease, and severe combined immunodeficiency between the first report and the present one shows an increase in the reporting of these diseases in all countries. In this report, the estimated minimal incidence of chronic granulomatous disease was between 0.72 and 1.26 cases per 100,000 births in Argentina, Chile, Costa Rica, and Uruguay and the incidence of severe combined immunodeficiency was 1.28 and 3.79 per 100,000 births in Chile and Costa Rica, respectively. However, these diseases are underreported in other participating countries. In addition to a better diagnosis of primary immunodeficiency diseases, more work on improving the registration of patients by each participating country and by countries that have not yet joined LAGID is still needed.

Birth Rate↗